Who makes [123] 5-I-A-85380?

[123] 5-I-A-85380 is developed by National Institute of Mental Health (NIMH).

What development phase is [123] 5-I-A-85380 in?

[123] 5-I-A-85380 is in Phase 2.

Last reviewed 2026-05-15 · How we verify

[123] 5-I-A-85380

National Institute of Mental Health (NIMH) · Phase 2 active Small molecule Quality 0/100

At a glance

Generic name	[123] 5-I-A-85380
Sponsor	National Institute of Mental Health (NIMH)
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

[123] 5-I-A-85380 CI brief — competitive landscape report
[123] 5-I-A-85380 updates RSS · CI watch RSS
National Institute of Mental Health (NIMH) portfolio CI